STCube, Inc.
Clinical trials sponsored by STCube, Inc., explained in plain language.
STCube, Inc.
052020
KOSDAQ
A biotech developing cancer immunotherapies based on its STC technology.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for lung cancer patients Who've run out of options? Results expected Aug 2027 (estimated)